Literature DB >> 35415750

Derisking Human Cytomegalovirus Vaccine Clinical Development in Relevant Preclinical Models.

Sallie R Permar1, Amitinder Kaur2, Klaus Fruh3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35415750      PMCID： PMC9441196          DOI： 10.1093/infdis/jiac131

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   7.759


× No keyword cloud information.
  19 in total

1.  Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus.

Authors:  Scott G Hansen; Colin J Powers; Rebecca Richards; Abigail B Ventura; Julia C Ford; Don Siess; Michael K Axthelm; Jay A Nelson; Michael A Jarvis; Louis J Picker; Klaus Früh
Journal:  Science       Date:  2010-04-02       Impact factor: 47.728

2.  The Status of Vaccine Development Against the Human Cytomegalovirus.

Authors:  Stanley A Plotkin; Dai Wang; Abdel Oualim; Don J Diamond; Camille N Kotton; Sally Mossman; Andrea Carfi; David Anderson; Philip R Dormitzer
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

3.  Horizontal Transmission of Cytomegalovirus in a Rhesus Model Despite High-Level, Vaccine-Elicited Neutralizing Antibody and T-Cell Responses.

Authors:  Julia Li; Sabine Wellnitz; Xiaoyuan S Chi; Yujuan Yue; Kimberli A Schmidt; Nancy Nguyen; Wei Chen; Irina Yurgelonis; Eduardo Rojas; Yuhang Liu; Jakob Loschko; Eneida Pollozi; Yury V Matsuka; Elie Needle; Eugene Vidunas; Robert G K Donald; Justin Moran; Kathrin U Jansen; Philip R Dormitzer; Peter A Barry; Xinzhen Yang
Journal:  J Infect Dis       Date:  2022-09-04       Impact factor: 7.759

4.  Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.

Authors:  Annalisa Macagno; Nadia L Bernasconi; Fabrizia Vanzetta; Erica Dander; Antonella Sarasini; Maria Grazia Revello; Giuseppe Gerna; Federica Sallusto; Antonio Lanzavecchia
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

5.  Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms.

Authors:  Scott G Hansen; Jonah B Sacha; Colette M Hughes; Julia C Ford; Benjamin J Burwitz; Isabel Scholz; Roxanne M Gilbride; Matthew S Lewis; Awbrey N Gilliam; Abigail B Ventura; Daniel Malouli; Guangwu Xu; Rebecca Richards; Nathan Whizin; Jason S Reed; Katherine B Hammond; Miranda Fischer; John M Turner; Alfred W Legasse; Michael K Axthelm; Paul T Edlefsen; Jay A Nelson; Jeffrey D Lifson; Klaus Früh; Louis J Picker
Journal:  Science       Date:  2013-05-24       Impact factor: 47.728

6.  Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys.

Authors:  Cody S Nelson; Diana Vera Cruz; Dollnovan Tran; Kristy M Bialas; Lisa Stamper; Huali Wu; Margaret Gilbert; Robert Blair; Xavier Alvarez; Hannah Itell; Meng Chen; Ashlesha Deshpande; Flavia Chiuppesi; Felix Wussow; Don J Diamond; Nathan Vandergrift; Mark R Walter; Peter A Barry; Michael Cohen-Wolkowiez; Katia Koelle; Amitinder Kaur; Sallie R Permar
Journal:  JCI Insight       Date:  2017-07-06

7.  Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.

Authors:  Felix Wussow; Flavia Chiuppesi; Joy Martinez; John Campo; Erica Johnson; Christin Flechsig; Maegan Newell; Elaine Tran; Jose Ortiz; Corinna La Rosa; Andreas Herrmann; Jeff Longmate; Rana Chakraborty; Peter A Barry; Don J Diamond
Journal:  PLoS Pathog       Date:  2014-11-20       Impact factor: 6.823

8.  Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia.

Authors:  Ilona Baraniak; Barbara Kropff; Gary R McLean; Sylvie Pichon; Fabienne Piras-Douce; Richard S B Milne; Colette Smith; Michael Mach; Paul D Griffiths; Matthew B Reeves
Journal:  J Infect Dis       Date:  2018-05-25       Impact factor: 5.226

9.  Prefusion structure of human cytomegalovirus glycoprotein B and structural basis for membrane fusion.

Authors:  Yuhang Liu; Kyle P Heim; Ye Che; Xiaoyuan Chi; Xiayang Qiu; Seungil Han; Philip R Dormitzer; Xinzhen Yang
Journal:  Sci Adv       Date:  2021-03-05       Impact factor: 14.136

10.  Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans.

Authors:  Jennifer A Jenks; Cody S Nelson; Hunter K Roark; Matthew L Goodwin; Robert F Pass; David I Bernstein; Emmanuel B Walter; Kathryn M Edwards; Dai Wang; Tong-Ming Fu; Zhiqiang An; Cliburn Chan; Sallie R Permar
Journal:  Sci Transl Med       Date:  2020-11-04       Impact factor: 19.319
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.